$Mepolizumab and exacerbations of refractory eosinophilic asthma.$

Mepolizumab and exacerbations of refractory eosinophilic asthma.

BACKGROUND: Exacerbations of asthma are associated with substantial morbidity and mortality and with considerable use of health care resources. Preventing exacerbations remains an important goal of therapy. There is evidence that eosinophilic inflammation of the airway is associated with the risk of...

Full description

Bibliographic Details
Main Authors:	Haldar, P, Brightling, C, Hargadon, B, Gupta, S, Monteiro, W, Sousa, A, Marshall, R, Bradding, P, Green, R, Wardlaw, A, Pavord, I
Format:	Journal article
Language:	English
Published:	2009

Mepolizumab and exacerbations of refractory eosinophilic asthma.

Similar Items